Concurrent Investment Advisors »

Rocket Pharmaceuticals shares owned by Concurrent Investment Advisors

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Concurrent Investment Advisors from 13F filings

Historical chart of Concurrent Investment Advisors investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Concurrent Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Concurrent Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $253k 71k 3.58
2025-12-31 $239k 68k 3.51
2025-09-30 $248k 76k 3.26
2025-06-30 $145k 59k 2.45

More positions owned by Concurrent Investment Advisors

Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation Call Option (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust State Street Spd (BIL)
First Tr Exchange-traded First Tr Enh New (FTSM)
Amazon (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Wal-Mart Stores (WMT)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Concurrent Investment Advisors

Top funds holding Rocket Pharmaceuticals

Rtw Investments
Vanguard Group
BlackRock
Citigroup
Vanguard Portfolio Management
Vanguard Capital Management
Maverick Capital
Newtyn Management
Nuveen
Millennium Management
AQR Capital Management
Geode Capital Management
D. E. Shaw & Co
Monaco Asset Management SAM
Morgan Stanley

View all funds holding Rocket Pharmaceuticals